Stock PHRX PHARMADRUG INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Pharmadrug Inc.

Equities

PHRX

CA71716W2040

Market Closed - Canadian Securities Exchange
Other stock markets
 15:21:59 2024-04-29 EDT 		5-day change 1st Jan Change
0.03 CAD 0.00% Intraday chart for Pharmadrug Inc. 0.00% -45.45%
04-16 PharmaTher Updated on its Priority Original Abbreviated New Drug Application for Ketamine MT
03-13 Pharmadrug's SecureDose Announces Filing of US Provisional Patent for Manufacturing Method for Biosynthetic Pharmaceutical Grade Cocaine CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
PharmaDrug's SecureDose Announces the Advancement of Process Development of Its Biosynthetic Formulation of Pharmaceutical Grade Cocaine
NE
PharmaTher Updated on its Priority Original Abbreviated New Drug Application for Ketamine
MT
Pharmadrug's SecureDose Announces Filing of US Provisional Patent for Manufacturing Method for Biosynthetic Pharmaceutical Grade Cocaine
CI
PharmaDrug's SecureDose Announces Filing of US Provisional Patent for Manufacturing Method for Biosynthetic Pharmaceutical Grade Cocaine
NE
PharmaDrug Inc Announces Board Changes
CI
PharmaDrug Appoints Current Board Member Dr. David Kideckel as Chairman
NE
PharmaTher Provides Update For PD-001
MT
PharmaDrug's Sairiyo Successfully Demonstrates Ability to Manufacture Cepharanthine (PD-001) for Human Clinical Studies
NE
Pharmadrug Inc. Announces Marketing and Distribution Services Agreement with Outside the Box Capital Inc
CI
PharmaDrug Inc. Engages Investor Relations and Marketing Service Providers
NE
PharmaDrug Inc. Announces Successful Closing of Non-Brokered Private Placement
NE
Pharmadrug Inc. announced that it has received CAD 0.326 million in funding
CI
PharmaDrug Inc. Announces Proposed Non-Brokered Private Placement
NE
Pharmadrug Inc. announced that it expects to receive CAD 0.326 million in funding
CI
PharmaDrug CEO Provides Vision for Securedose Acquisition
NE
PharmaDrug Inc. Completes Debt Restructuring
NE
PharmaDrug Inc. Announces Grant of Stock Options
NE
PharmaDrug Inc. Closes Acqusition of Securedose Synthetics
NE
Pharmadrug Inc. completed the acquisition of Securedose Synthetics Inc.
CI
Pharmadrug Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PHRX Stock
  4. News Pharmadrug Inc.